New study identifies structural basis of CysLT2R activation by LTD4, paving way for new blocking therapies
Cysteinyl leukotrienes (CysLTs) are potent bronchoconstrictors, playing pivotal roles in inflammatory diseases. These lipid mediators exert their effects by activating two G protein-coupled receptors, CysLT1R and CysLT2R. ...